An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis.
Lewis JD, Lichtenstein GR, Stein RB, Deren JJ, Judge TA, Fogt F, Furth EE, Demissie EJ, Hurd LB, Su CG, Keilbaugh SA, Lazar MA, Wu GD.
Lewis JD, et al.
Am J Gastroenterol. 2001 Dec;96(12):3323-8. doi: 10.1111/j.1572-0241.2001.05333.x.
Am J Gastroenterol. 2001.
PMID: 11774944